Flow cytometric analysis of peripheral blood from MS patients and healthy controls demonstrated that MS patients have significantly lower levels of CD4+ T lymphocytes and CD3+ T lymphocytes, but significantly higher levels of NK T cells (CD3+CD16+CD56+) (91). The gene discussed is CD4; the disease is myeloid sarcoma.